Cairong Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Cairong Li has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Yuxiao Lai
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
5 shared publications - Wei Zhang
Centre for Translational Medicine Research & Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
4 shared publications Ling Qin
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, PR China
2 shared publications- Yangyi Nie
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
2 shared publications Deju Gao
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, PR China
1 shared publication- Deju Gao
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
1 shared publication
Latest Publications
- Open Access
- 21 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1093
Multifunctional Roles of Magnesium Ions in Modulating Bone Regeneration-Related Cells
Magnesium ions (Mg2+) play pivotal roles in bone regeneration by regulating the biological functions of multiple bone repair-related cells. However, the effective concentration ranges and optimal concentration of Mg2+ for different cell types remain incompletely defined, which limits the precise design of Mg-containing biomaterials with controllable ion release for repairing of bone defects. In this study, the concentration-dependent effects of Mg2+ on the biological functions of bone regeneration-related cells were systematically investigated. Human bone marrow mesenchymal stem cells (hBMSCs), human umbilical vein endothelial cells (HUVECs), rat Schwann cells (RSCs), and RAW264.7 macrophage were selected to evaluate the effective concentration of Mg2+ for promoting osteogenesis, angiogenesis, neuroregulation, and immunomodulation, respectively. The results demonstrated that Mg2+ concentrations ranging from to 16 mM, particularly 8 mM, significantly upregulated the expression of M2 macrophage-related markers, thereby promoting the polarization of RAW264.7 macrophages toward the anti-inflammatory M2 phenotype. Moreover, Mg2+ concentrations between 2 and 8 mM effectively enhanced the osteogenic activity of hBMSCs, the angiogenic activity of HUVECs, and the neuroregulatory function of RSCs, as confirmed by immunofluorescence staining and quantitative PCR analysis of osteogenic, angiogenic, and neuroregulation-related marker expression. These findings provide a comprehensive understanding of the concentration-dependent biological effects of Mg2+ on bone regeneration-related cells and establish a theoretical basis for the rational design of next-generation Mg2+-releasing biomaterials with precise biological regulation.
- 21 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1093
Open AccessMultifunctional Roles of Magnesium Ions in Modulating Bone Regeneration-Related Cells
Magnesium ions (Mg2+) play pivotal roles in bone regeneration by regulating the biological functions of multiple bone repair-related cells. However, the effective concentration ranges and optimal concentration of Mg2+ for different cell types remain incompletely defined, which limits the precise design of Mg-containing biomaterials with controllable ion release for repairing of bone defects. In this study, the concentration-dependent effects of Mg2+ on the biological functions of bone regeneration-related cells were systematically investigated. Human bone marrow mesenchymal stem cells (hBMSCs), human umbilical vein endothelial cells (HUVECs), rat Schwann cells (RSCs), and RAW264.7 macrophage were selected to evaluate the effective concentration of Mg2+ for promoting osteogenesis, angiogenesis, neuroregulation, and immunomodulation, respectively. The results demonstrated that Mg2+ concentrations ranging from to 16 mM, particularly 8 mM, significantly upregulated the expression of M2 macrophage-related markers, thereby promoting the polarization of RAW264.7 macrophages toward the anti-inflammatory M2 phenotype. Moreover, Mg2+ concentrations between 2 and 8 mM effectively enhanced the osteogenic activity of hBMSCs, the angiogenic activity of HUVECs, and the neuroregulatory function of RSCs, as confirmed by immunofluorescence staining and quantitative PCR analysis of osteogenic, angiogenic, and neuroregulation-related marker expression. These findings provide a comprehensive understanding of the concentration-dependent biological effects of Mg2+ on bone regeneration-related cells and establish a theoretical basis for the rational design of next-generation Mg2+-releasing biomaterials with precise biological regulation.
- Open Access
Exosomes Derived from Mg-Preconditioned Bone Mesenchymal Stem Cells Promote Angiogenesis and Osteogenesis for Osteonecrosis Treatment
Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory orthopedic disorder, often resulting from prolonged or high-dose glucocorticoid use that impairs bone repair and vascularization. The critical impact of exosomes derived from bone mesenchymal stem cells (BMSCs) in bone regeneration has drawn increasing attention. In this study, we developed a novel type of exosomes derived from Magnesium-preconditioned BMSCs (Mg-Exos) and evaluated their therapeutic potential. In vitro experiments demonstrated that Mg-Exos effectively counteracted Dex-induced impairment in the angiogenic function of human umbilical vein endothelial cells (HUVECs) and the osteogenic differentiation of BMSCs. These findings highlight the promise of Mg-Exos as a potential cell-free therapeutic strategy for SONFH, acting through the concurrent enhancement of vascularization and bone formation. Consequently, this work lays a solid foundation for the future application of Mg-Exos in treating SONFH.
Open AccessExosomes Derived from Mg-Preconditioned Bone Mesenchymal Stem Cells Promote Angiogenesis and Osteogenesis for Osteonecrosis Treatment
Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory orthopedic disorder, often resulting from prolonged or high-dose glucocorticoid use that impairs bone repair and vascularization. The critical impact of exosomes derived from bone mesenchymal stem cells (BMSCs) in bone regeneration has drawn increasing attention. In this study, we developed a novel type of exosomes derived from Magnesium-preconditioned BMSCs (Mg-Exos) and evaluated their therapeutic potential. In vitro experiments demonstrated that Mg-Exos effectively counteracted Dex-induced impairment in the angiogenic function of human umbilical vein endothelial cells (HUVECs) and the osteogenic differentiation of BMSCs. These findings highlight the promise of Mg-Exos as a potential cell-free therapeutic strategy for SONFH, acting through the concurrent enhancement of vascularization and bone formation. Consequently, this work lays a solid foundation for the future application of Mg-Exos in treating SONFH.
- Open Access
- 5 September 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 55, 75-93
3D bioprinting bone/cartilage organoids: construction, applications, and challenges
- 5 September 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 55, 75-93
Open Access3D bioprinting bone/cartilage organoids: construction, applications, and challenges
- 29 April 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (22) , 4242-4253
Preparation and characterization of photocurable composite extracellular matrix-methacrylated hyaluronic acid bioink
Producing a bioink that fulfills the physicochemical requirements of printing and provides a desirable environment for encapsulated cells is a major challenge in three-dimensional (3D) bioprinting. Thus, we have developed a biocompatible bioink (ECM@MeHA bioink) with suitable mechanical support and visible light printable properties. In this bioink system, the thermosensitive extracellular matrix (ECM) was prepared and can be crosslinked at 37 °C. And the prepared methacrylated hyaluronic acid (MeHA) can be crosslinked under visible light using the biosafe initiators (Eosin Y, TEOA, and NVP). Thus, the ECM@MeHA bioink consisted of a mix solution of ECM and MeHA containing visible light initiators can cure at 515 nm visible light for 30 s and then further crosslinked at 37 °C to form a double network hydrogel. Then, the mechanical properties and biocompatibility of ECM@MeHA hydrogel, and the printability and the cell viability of the ECM@MeHA bioink were systemically evaluated. The results showed that the mechanical property of the MeHA hydrogel is significantly improved following the addition of 10 mg mL−1 of ECM (10ECM@MeHA). The compressive strength and modulus of 10ECM@MeHA hydrogel were 102.38 ± 5.27 kPa and 782 ± 20.36 kPa, which were 2.7 times and 3.1 times higher than those of MeHA, respectively. After encapsulating MC3T3-E1 cells in the 10ECM@MeHA hydrogel for 7 days, the culture showed excellent biocompatibility. The 10ECM@MeHA bioink and cell–laden 10ECM@MeHA bioink were printed, and the cells were successfully encapsulated by the extrusion-based bioprinting and digital light processing (DLP) -based bioprinting. The cell–laden 10ECM@MeHA scaffold showed 94.27 ± 3.00% cell viability after 7 days of the 3D culture. In conclusion, 10ECM@MeHA bioink may provide a new strategy for constructing disease models or drug screening models in vitro and is expected to be widely used in the field of tissue engineering scaffolds.
- 29 April 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (22) , 4242-4253
Preparation and characterization of photocurable composite extracellular matrix-methacrylated hyaluronic acid bioink
Producing a bioink that fulfills the physicochemical requirements of printing and provides a desirable environment for encapsulated cells is a major challenge in three-dimensional (3D) bioprinting. Thus, we have developed a biocompatible bioink (ECM@MeHA bioink) with suitable mechanical support and visible light printable properties. In this bioink system, the thermosensitive extracellular matrix (ECM) was prepared and can be crosslinked at 37 °C. And the prepared methacrylated hyaluronic acid (MeHA) can be crosslinked under visible light using the biosafe initiators (Eosin Y, TEOA, and NVP). Thus, the ECM@MeHA bioink consisted of a mix solution of ECM and MeHA containing visible light initiators can cure at 515 nm visible light for 30 s and then further crosslinked at 37 °C to form a double network hydrogel. Then, the mechanical properties and biocompatibility of ECM@MeHA hydrogel, and the printability and the cell viability of the ECM@MeHA bioink were systemically evaluated. The results showed that the mechanical property of the MeHA hydrogel is significantly improved following the addition of 10 mg mL−1 of ECM (10ECM@MeHA). The compressive strength and modulus of 10ECM@MeHA hydrogel were 102.38 ± 5.27 kPa and 782 ± 20.36 kPa, which were 2.7 times and 3.1 times higher than those of MeHA, respectively. After encapsulating MC3T3-E1 cells in the 10ECM@MeHA hydrogel for 7 days, the culture showed excellent biocompatibility. The 10ECM@MeHA bioink and cell–laden 10ECM@MeHA bioink were printed, and the cells were successfully encapsulated by the extrusion-based bioprinting and digital light processing (DLP) -based bioprinting. The cell–laden 10ECM@MeHA scaffold showed 94.27 ± 3.00% cell viability after 7 days of the 3D culture. In conclusion, 10ECM@MeHA bioink may provide a new strategy for constructing disease models or drug screening models in vitro and is expected to be widely used in the field of tissue engineering scaffolds.
- Open Access
- 22 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2401
Recent Advances of Microneedles and Their Application in Disease Treatment
For decades, scientists have been doing a lot of research and exploration to find effective long-term analgesic and/or disease-modifying treatments. Microneedles (MNs) are a simple, effective, and painless transdermal drug delivery technology that has emerged in recent years, and exhibits great promise for realizing intelligent drug delivery. With the development of materials science and fabrication technology, the MN transdermal drug delivery technology has been applied and popularized in more and more fields, including chronic illnesses such as arthritis or diabetes, cancer, dermatocosmetology, family planning, and epidemic disease prevention, and has made fruitful achievements. This paper mainly reviews the latest research status of MNs and their fabrication methodology, and summarizes the application of MNs in the treatment of various diseases, as well as the potential to use nanotechnology to develop more intelligent MNs-based drug delivery systems.
- 22 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2401
Open AccessRecent Advances of Microneedles and Their Application in Disease Treatment
For decades, scientists have been doing a lot of research and exploration to find effective long-term analgesic and/or disease-modifying treatments. Microneedles (MNs) are a simple, effective, and painless transdermal drug delivery technology that has emerged in recent years, and exhibits great promise for realizing intelligent drug delivery. With the development of materials science and fabrication technology, the MN transdermal drug delivery technology has been applied and popularized in more and more fields, including chronic illnesses such as arthritis or diabetes, cancer, dermatocosmetology, family planning, and epidemic disease prevention, and has made fruitful achievements. This paper mainly reviews the latest research status of MNs and their fabrication methodology, and summarizes the application of MNs in the treatment of various diseases, as well as the potential to use nanotechnology to develop more intelligent MNs-based drug delivery systems.